Seminars in Nephrology
Volume 29, Issue 2 , Pages 166-173 , March 2009

Bone Disease in Kidney Transplant Patients

  • Minna Huang, MD
    • ,
  • Stuart M. Sprague, DO

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Stuart M. Sprague, DO, Division of Nephrology and Hypertension, NorthShore University HealthSystem, 2650 Ridge Ave, Evanston, IL 60201

References 

  1. Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, et al. Osteoporotic Fractures Research Group Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007;167:133–139
  2. Lindberg JS, Moe SM. Osteoporosis in end-state renal disease. Semin Nephrol. 1999;19:115–122
  3. Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, et al. Increased risk of fracture in patients receiving solid organ transplants. J Bone Mineral Res. 1999;14:456–463
  4. Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporosis Int. 2003;14:617–630
  5. Sprague SM, Josephson M. Bone disease after kidney transplantation. Semin Nephrol. 2004;24:82–90
  6. Brandenburg VM, Ketteler M, Fassbender WJ, Heussen N, Freuding T, Floege J, et al. Development of lumbar bone mineral density in the late course after kidney transplantation. Am J Kidney Dis. 2002;40:1066
  7. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med. 1991;325:544–550
  8. Almond MK, Kwan JT, Evans K, Cunningham J. Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron. 1994;66:52–57
  9. Sprague SM, Belozeroff V, Danese M, Martin L, Olgaard K. Abnormal bone and mineral metabolism in kidney transplant patients—a review. Am J Nephrol. 2008;28:246–253
  10. Martin K, Al-Aly Z, Gonzalez E. Renal osteodystrophy. Primer on the metabolic bone diseases and disorders of mineral metabolism. 2006;66:359–366
  11. Zhang R, Alper B, Simon E, Florman S, Slakey D. Management of metabolic bone disease in kidney transplant recipients. Am J Med Sci. 2008;335:120–125
  12. Schlosberg M, Movsoqitz C, Epstein S, Ismail F, Fallon T. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology. 1989;124:2179
  13. Orcel P, Denne M, De Vernejoul M. Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology. 1991;128:1638
  14. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res. 1996;11:1–7
  15. Rojas E, Carlini RG, Clesca P, Arminio A, Suniaga O, De Elguezabal K, et al. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int. 2003;63:1915–1923
  16. Lehmann G, Ott U, Stein G, Steiner T, Wolf G. Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients. Transplant Proc. 2007;39:3153–3158
  17. Cueto-Manzano AM, Konel S, Hutchison AJ, Crowley V, France MW, Freemont AJ, et al. Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int. 1999;55:2021–2029
  18. Giannini S, D'Angelo A, Carraro G, Antonello A, Di LD, et al. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation. Clin Nephrol. 2001;56:353–363
  19. Kusec V, Smalcelj R, Cvijetic S, Rozman B, Skreb F. Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: cross-sectional study. Croat Med J. 2000;41:396–400
  20. Rubello D, Giannini S, D'Angelo A, Nobile M, Carraio G, et al. Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation. Biomed Pharmacother. 2005;59:402–407
  21. Kim H, Chang K, Lee T, Kwon J, Park S. Bone mineral density after renal transplantation. Transplant Proc. 1998;30:3029–3030
  22. D'Angelo A, Calò L, Giannini S, Carraro G, Bonfante L, Favaro S, et al. Parathyroid hormone and bone metabolism in kidney-transplanted patients. Clin Nephrol. 2000;53:19–22
  23. Brandenburg VM, Ketteler M, Fassbender WJ, Heussen N, Freuding T, Floege J, et al. Development of lumbar bone mineral density in the late course after kidney transplantation. Am J Kidney Dis. 2002;40:1066–1074
  24. Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N. Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant. 2000;14:457–463
  25. Cayco AV, Wysolmerski J, Simpson C, Mitnick MA, Gundberg C, Kliger A, et al. Posttransplant bone disease: evidence for a high bone resorption state. Transplantation. 2000;70:1722–1728
  26. Reusz GS, Szabó AJ, Péter F, Kenesei E, Sallay P, Latta K, et al. Bone metabolism and mineral density following renal transplantation. Arch Dis Child. 2000;83:146–151
  27. Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ. Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int. 1993;3:322–329
  28. Garcia-Delgado I, Prieto S, Gil-Fraguas L, Robles E, Rufilanchas JJ, Hawkins F. Calcitonin, etidronate and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int. 1997;60:155–159
  29. Josephson MA, Schumm LP, Chiu MY, Marshall C, Thistlewaite JR, Sprague SM. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation. 2004;78:1233–1236
  30. Fan SL, Almond MK, Ball E, Evans K, Cunningham J. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int. 2000;57:684–690
  31. Fan SL, Kumar S, Cunningham J. Long term effects on bone mineral density of pamidronate given at the time of renal transplantation. Kidney Int. 2003;63:2275–2279
  32. Torregrosa JV, Fuster D, Pedrosa S, Diekmann F, Campistol JM, Rubi S, et al. Weekly risendronate in kidney transplant patients with osteopenia. Transplant Int. 2007;20:708–711
  33. Jeffrey JR, Leslie WD, Karpinski ME, Nickerson PW, Rush DN. Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. Transplantation. 2003;76:1498–1502
  34. Coco M, Glicklich D, Faugere MC, Burris L, Bognar I, Durkin P, et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol. 2003;14:2669–2676
  35. Serra AL, Schwarz AA, Wick FH, Marti HP, Wüthrich RP. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2005;20:1315–1319
  36. Kruse A, Eisenberger U, Frey F, Mohaupt M. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2005;20:1311–1314
  37. Bergua C, Torregrosa JV, Fuster D, Gutierrez-Dalmau A, Oppenheimer F, Campistol J. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation. 2008;86:413–417
  38. Cejka D, Benesch T, Krestan C, Roschger P, Klaushofer K, Pietschmann P, et al. Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplantation. 2008;8:1864–1870
  39. Nowacka-Cieciura E, Cieciura T, Baczkowska T, Kozińska-Przybył O, Tronina O, Chudziński W, et al. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. Transplant Proc. 2006;38:165–167
  40. Grotz W, Nagel C, Poeschel D, Cybulla M, Peterson KG, Uhl M, et al. Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol. 2001;12:1530–1537
  41. Leca N, Laftavi M, Gundroo A, Kohli R, Min I, Karam J, et al. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant. 2006;6:2391–2395
  42. Srinivas JR, Scholol JD, Womer KL, Kaplan C, Howard RJ, Bucci CM, et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol. 2006;1:323–326
  43. Szwarc I, Argiles A, Garrique V, Delmas P, Chong G, Deleuze S, et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with post-transplant hyperparathyroidism. Transplantation. 2006;82:675–680

PII: S0270-9295(09)00010-2

doi: 10.1016/j.semnephrol.2009.01.009

Seminars in Nephrology
Volume 29, Issue 2 , Pages 166-173 , March 2009

Article Tools

* Image Usage & Resolution